EP3042669
Æxliseyðandi miðill og eflir fyrir æxliseyðandi áhrif
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.9.2014EP published:
8.3.2023EP application number:
14842538.2
EP translation filed:
5.6.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
4.9.2034Expiry date:
4.9.2026Next due date:
30.9.2026
Title in English:
ANTITUMOR AGENT AND ANTITUMOR EFFECT ENHANCERLanguage of the patent:
English
Timeline
Today
5.9.2014EP application
8.3.2023EP Publication
5.6.2023Translation submitted
15.7.2023Registration published
4.9.2026Expires
Owner
Name:
Taiho Pharmaceutical Co., Ltd.Address:
1-27, Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, JP
Inventor
Name:
OKABE, HiroyukiAddress:
Tsukuba-shi Ibaraki 300-2611, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2013184684Date:
6.9.2013Country:
JP
Supplementary protection
SPC number:
SPC452
Classification
Categories:
A61K 39/395, A61K 31/506, A61K 31/7072, A61P 35/00, A61P 43/00, A61K 31/513, C07K 16/22, C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 31.8.2023
Expires: 4.9.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.8.2024
Expires: 4.9.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 21.8.2025
Expires: 4.9.2026
Payer: Árnason Faktor ehf.